Berberine

📜 Historical Use

Berberine is an isoquinoline alkaloid and the yellow pigment found in a number of unrelated plants, among them Berberis species such as barberry and Oregon grape, Coptis chinensis, and goldenseal. Preparations of these plants have long histories in both traditional Chinese medicine and Ayurveda, which is why berberine is often described as a traditional remedy even though the isolated compound sold today is a modern extract rather than a traditional preparation.

📊 What the Research Shows

The evidence base is suggestive rather than settled, and the quality of it is the main caveat. A 2012 systematic review and meta-analysis of berberine in type 2 diabetes (Dong et al., Evidence-Based Complementary and Alternative Medicine; PMID 23118793) was followed by a 2021 meta-analysis of metabolic profiles in type 2 diabetic patients (Guo et al., Oxidative Medicine and Cellular Longevity; PMID 34956436) and a 2024 umbrella meta-analysis covering glycemic control and inflammatory markers across metabolic disorders (Nazari et al., Clinical Therapeutics; PMID 38016844). Memorial Sloan Kettering's clinical summary notes that the dyslipidemia trials underpinning these analyses were heterogeneous, of low quality, or carried a high risk of bias, and that berberine may be more helpful in younger patients or over shorter treatment periods. An expert panel consensus holds that it may have a role in mild hypercholesterolemia specifically for patients who cannot tolerate statins. Separately, berberine has been shown to lower the risk of recurrence of colorectal adenoma. None of this establishes it as a substitute for prescribed therapy.

Take 500mg 2-3 times daily before meals.

Do not take if pregnant or nursing. Can interact with liver-metabolized medications.

⚠️ What happens if taken in excess:

Berberine is generally well tolerated, and reported side effects are mild and mostly digestive: loss of appetite, upset stomach, diarrhea, constipation, and rash. The important restriction is not dose-related but population-related. Berberine should be avoided in pregnancy and during breastfeeding, because it may worsen jaundice in infants or result in kernicterus — a form of permanent brain injury caused by bilirubin. It should not be given to newborns or infants.

This is the section that matters most for anyone taking prescription medication, because berberine is a meaningful enzyme inhibitor rather than an inert botanical. Repeated oral intake significantly decreases the activity of CYP2D6, CYP2C9 and CYP3A4 — three of the enzymes responsible for clearing a large share of common prescriptions, so blood levels of those drugs can rise. Documented specifics: berberine increased blood concentrations of both tacrolimus and cyclosporine, causing renal toxicity in reported cases, so it should not be combined with these immunosuppressants. Simulations predict a moderate 1.3-fold increase in systemic exposure to bosutinib. In vitro studies indicate that co-administration may compromise the metabolism of sulfonylureas, although the clinical significance of that is not yet established. Because berberine lowers blood glucose in its own right, combining it with any glucose-lowering drug raises the possibility of additive effects and should be supervised.

1. Efficacy of berberine in patients with type 2 diabetes — Yin J, Xing H, Ye J Metabolism (Elsevier) (2008)[doi ↗]
2. Treatment of type 2 diabetes and dyslipidemia with berberine — Zhang Y et al J Clin Endocrinol Metab (Oxford Academic) (2008)[doi ↗]
3. Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular Metabolic Diseases — Neag MA et al Front Pharmacol (Frontiers) (2018)[doi ↗]